Nano Dimension Ltd.
4.20%
9,057,952
1643303
63008G203
Jul 10, 2025
Jul 14, 2025, 05:42 PM
Reporting Persons (6)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Anson Funds Management LP | Investment Adviser | 4.20% | 9,057,952 | 0 | 9,057,952 |
| Anson Management GP LLC | Holding Company | 4.20% | 9,057,952 | 0 | 9,057,952 |
| Tony Moore | Individual | 4.20% | 9,057,952 | 0 | 9,057,952 |
| Anson Advisors Inc. | CO | 4.20% | 9,057,952 | 0 | 9,057,952 |
| Amin Nathoo | Individual | 4.20% | 9,057,952 | 0 | 9,057,952 |
| Moez Kassam | Individual | 4.20% | 9,057,952 | 0 | 9,057,952 |
Disclosure Items (4)
Ordinary Shares, NIS 5.00 par value
Nano Dimension Ltd.
2 ILAN RAMON, NESS ZIONA, L3, 7403635
The ADSs representing the Ordinary Shares reported herein as being beneficially owned by the Reporting Persons were purchased using working capital of the Funds. An aggregate of approximately $24,869,497.71 (excluding brokerage commissions) was used to purchase ADSs representing Ordinary Shares reported as beneficially owned by the Reporting Persons in this Schedule 13D. Such securities were acquired through open market purchases.
See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of Ordinary Shares and percentages of the Ordinary Shares beneficially owned by each of the Reporting Persons. The percentages used in this Schedule 13D are calculated based upon 217,283,476 shares outstanding as of April 30, 2025, as reported in Issuer's Report of Foreign Private Issuer on Form 20-F filed with the Securities and Exchange Commission on May 12, 2025.
See rows (7) through (10) of the cover pages to this Schedule 13D for the number of Ordinary Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.
The transactions by the Reporting Persons in the ADSs of the Issuer since the filing of Amendment No. 5, which were all in the open market, are set forth in Schedule A. In addition, on July 11, 2025.
July 11, 2025
The Funds no longer hold the Derivative Agreements previously reported in Amendment No. 5 of the Schedule 13D.